Imaging Characteristics of Primary Cardiac Angiosarcoma

HU Tingting; GUO Lilin; ZHU Yuanyuan; TIAN Zhuang

doi:10.12376/j.issn.2097-0501.2023.01.012

Journal of Rare Diseases > 2023 > 2(1): 88-97. > DOI: 10.12376/j.issn.2097-0501.2023.01.012

HU Tingting, GUO Lilin, ZHU Yuanyuan, TIAN Zhuang. Imaging Characteristics of Primary Cardiac Angiosarcoma[J]. Journal of Rare Diseases, 2023, 2(1): 88-97. DOI: 10.12376/j.issn.2097-0501.2023.01.012

Citation:

PDF (2314 KB)

Imaging Characteristics of Primary Cardiac Angiosarcoma

1.
Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
2.
Department of International Medical Services, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds:

Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences 2021-I2M-1-003

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-098

More Information

Corresponding author:
TIAN Zhuang, E-mail: tianzhuangcn@sina.com
Received Date: December 05, 2022
Accepted Date: December 20, 2022
Available Online: March 06, 2023

Graphical Abstract

Abstract

Abstract

Primary cardiac angiosarcoma is a type of soft tissue sarcoma originating in vascular endothelial cells, without obvious gender differences in the incidence rate and specific early clinical manifestations, whilstpericardial effusion often found at the first presentation of most patients. Tumors are mostly located in the right atrium and pericardium. Echocardiography is the preferred examination method for diagnosing cardiac angiosarcoma and multimodal imaging is important in the diagnosis and differential diagnosis of benign and malignant cardiac mass. This article retrospectively analyzes the 25 cases of clinical manifestations and imaging features of primary cardiac angiosarcoma.
- angiosarcoma,
- cardiac,
- echocardiography,
- imaging

FullText(HTML)

References (17)

References

[1]	Randhawa JS, Budd GT, Randhawa M, et al. Primary cardiac sarcoma: 25-year cleveland clinic experience[J]. Am J Clin Oncol, 2016, 39(6): 593-599. doi: 10.1097/COC.0000000000000106
[2]	Florou V, Wilky BA. Current management of angiosarcoma: recent advances and lessons from the past[J]. Curr Treat Options Oncol, 2021, 22(7): 61. doi: 10.1007/s11864-021-00858-9
[3]	Butany J, Yu W. Cardiac angiosarcoma: two cases and a review of the literature[J]. Can J Cardiol, 2000, 16(2): 197-205.
[4]	Riles E, Gupta S, Wang DD, et al. Primary cardiac angiosarcoma: a diagnostic challenge in a young man with recurrent pericardial effusions[J]. Exp Clin Cardiol, 2012, 17(1): 39-42.
[5]	Tang QY, Guo LD, Wang WX, et al. Usefulness of contrast perfusion echocardiography for differential diagnosis of cardiac masses[J]. Ultrasound Med Biol, 2015, 41(9): 2382-2390. doi: 10.1016/j.ultrasmedbio.2015.05.010
[6]	Chen Y, Li Y, Zhang N, et al. Clinical and imaging features of primary cardiac angiosarcoma[J]. Diagnostics (Basel), 2020, 10(10): 776. doi: 10.3390/diagnostics10100776
[7]	Li X, Lan L, Hu H. Case report: primary cardiac angiosarcoma with multiple metastases[J]. Front Cardiovasc Med, 2022, 9: 941967. doi: 10.3389/fcvm.2022.941967
[8]	Yu JF, Cui H, Ji GM, et al. Clinical and imaging manifestations of primary cardiac angiosarcoma[J]. BMC Med Imaging, 2019, 19(1): 16. doi: 10.1186/s12880-019-0318-4
[9]	Araoz PA, Eklund HE, Welch TJ, et al. CT and MR imaging of primary cardiac malignancies[J]. Radiographics, 1999, 19(6): 1421-1434. doi: 10.1148/radiographics.19.6.g99no031421
[10]	Göbölös L, Bhatnagar G. Angiosarcoma of the heart[J]. JACC Case Rep, 2021, 3(6): 950-953. doi: 10.1016/j.jaccas.2021.04.030
[11]	Yin H, Mao W, Tan H, et al. Role of (18)F-FDG PET/CT imaging in cardiac and pericardial masses[J]. J Nucl Cardiol, 2022, 29(3): 1293-1303. doi: 10.1007/s12350-020-02510-9
[12]	Yaddanapudi K, Brunken R, Tan CD, et al. PET-MR imaging in evaluation of cardiac and paracardiac masses with histopathologic correlation[J]. JACC Cardiovasc Imaging, 2016, 9(1): 82-85. doi: 10.1016/j.jcmg.2015.04.028
[13]	Bruce CJ. Cardiac tumours: diagnosis and management[J]. Heart, 2011, 97(2): 151-160. doi: 10.1136/hrt.2009.186320
[14]	Masood I, Duran C, Malik K, et al. Uterineintravenous leiomyomatosis with cardiac involvement[J]. Radiol Case Rep, 2020, 15(8): 1389-1393. doi: 10.1016/j.radcr.2020.05.053
[15]	Li X, Chen Y, Liu J, et al. Cardiac magnetic resonance imaging of primary cardiac tumors[J]. Quant Imaging Med Surg, 2020, 10(1): 294-313. doi: 10.21037/qims.2019.11.13
[16]	Kupsky DF, Newman DB, Kumar G, et al. Echocardiographic features of cardiac angiosarcomas: the mayo clinic experience (1976-2013)[J]. Echocardiography, 2016, 33(2): 186-192. doi: 10.1111/echo.13060
[17]	Hammami MB, Al-Wawi MZ, Fazel H, et al. Incidence, prognostic significance, and survival outcomes of primary cardiac sarcoma: an updated population-based retrospective study[J]. Anatol J Cardiol, 2021, 25(2): 104-110.

[1]	XIE Shiyao, LIU Ziyu, LI Shunping. Present Situation and Countermeasures of China′s Legal Responses to Rare Diseases[J]. Journal of Rare Diseases, 2024, 3(3): 405-410. DOI: 10.12376/j.issn.2097-0501.2024.03.021
[2]	DONG Xinran, ZHOU Wenhao. Work Plan for the Clinical Utility & Usefulness Measures Working Group of Medical Genome Committee[J]. Journal of Rare Diseases, 2024, 3(3): 304-309. DOI: 10.12376/j.issn.2097-0501.2024.03.005
[3]	DONG Xinran, ZHOU Wenhao. The China Neonatal Genomes Project(CNGP): New Advances in the Cohort Study of Genotype and Phenotype of Rare Diseases[J]. Journal of Rare Diseases, 2024, 3(3): 280-287. DOI: 10.12376/j.issn.2097-0501.2024.03.002
[4]	LI Kexin, CHEN Jingdan, ZHANG Dingding, GUO Wudong, ZHENG Jiayin, LI Linkang, ZHAO Kun, ZHANG Shuyang. Thoughts on Selection of Rare Diseases and Prioritized Research Topics[J]. Journal of Rare Diseases, 2024, 3(2): 269-274. DOI: 10.12376/j.issn.2097-0501.2024.02.018
[5]	WANG Shaohong, LIU Xin, LIU Qingyang, TANG Yan, ZHANG Bo. Overview and Analysis of Rare Disease Drugs Approved for Market in China, the United States, the European Union, and Japan in 2023[J]. Journal of Rare Diseases, 2024, 3(2): 202-213. DOI: 10.12376/j.issn.2097-0501.2024.02.008
[6]	LIU Qingyang, LIU Xin, ZUO Wei, WANG Shaohong, ZHANG Bo, ZHANG Shuyang. Study on Drug List and Accessibility of Rare Diseases Based on the China′s Second List of Rare Diseases[J]. Journal of Rare Diseases, 2024, 3(2): 195-201. DOI: 10.12376/j.issn.2097-0501.2024.02.007
[7]	LI Kexin, ZHAO Kun, ZHENG Jiayin, YANG Yuqi, LI Linkang. Current Status of Drug Development and Implementation for Diseases Included in the Second Catalog of Rare Diseases[J]. Journal of Rare Diseases, 2023, 2(4): 596-601. DOI: 10.12376/j.issn.2097-0501.2023.04.015
[8]	ZHANG Xueyi, SUN Bo, CHEN Guilin, HU Ge, LI Qing, QIU Guixing. Computer Vision in Medical Imaging and its Impact on the Rare Musculoskeletal Diseases[J]. Journal of Rare Diseases, 2023, 2(4): 589-595. DOI: 10.12376/j.issn.2097-0501.2023.04.014
[9]	TAO Libo, WANG Fangxu, JIA Fanghong, YANG Yulin, ZHENG Jiayin, ZHANG Shuyang. The Exploration and Analysis of Constructing a Multiple Health Security System for Rare Diseases in China[J]. Journal of Rare Diseases, 2023, 2(1): 135-142. DOI: 10.12376/j.issn.2097-0501.2023.01.019
[10]	ZHANG Haiqin, LI Shunping, FENG Junchao. Application Status, Problems and Suggestions of Commerical Health Insurance in Medical Security for Rare Dsieases in China[J]. Journal of Rare Diseases, 2022, 1(1): 84-88. DOI: 10.12376/j.issn.2097-0501.2022.01.014

Cited By

Get Citation

PDF

XML

Article views (215) PDF downloads (52)

Turn off MathJax

Article Contents

Abstract

References

Imaging Characteristics of Primary Cardiac Angiosarcoma

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content